NCT06505824View on ClinicalTrials.gov

A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 2, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Small Cell Lung CancerNeuroendocrine Tumors
Interventions
DRUG

BL-M14D1

Administration by intravenous infusion for a cycle of 3 weeks.

Trial Locations (1)

Unknown

RECRUITING

Shanghai East Hospital, Shanghai

All Listed Sponsors
collaborator

Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

INDUSTRY

lead

Sichuan Baili Pharmaceutical Co., Ltd.

INDUSTRY